Travere Therapeutics Inc.
TVTX | NASDAQ
$60.81
-$2.05 (-3.26%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 93.04M | 58.54M | 58.18M | 61.69M | 165.75M | 84.77M |
Short-Term Investments | 229.76M | 312.17M | 508.68M | 388.56M | 387.13M | 276.82M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 39.16M | 53.82M | 42.16M | 59.03M | 11.07M | 33.49M |
Receivables | 80.13M | 27.12M | 21.18M | 16.65M | 15.91M | 33.07M |
Inventory | 5.88M | 6.2M | 9.41M | 4.52M | 7.31M | 7.61M |
Other Current Assets | 28.76M | 12.69M | 19.34M | 15.02M | 247K | n/a |
Total Current Assets | 437.57M | 416.7M | 616.78M | 486.44M | 582.83M | 410.41M |
Property-Plant & Equipment | 14.6M | 19.63M | 25.54M | 30.05M | 34.3M | 9.42M |
Goodwill & Intangibles | 113.12M | 103.97M | 104.44M | 97.12M | 148.4M | 154.13M |
Total Long-Term Assets | 166.87M | 177.42M | 172.14M | 186.2M | 193.77M | 197.03M |
Total Assets | 605.19M | 594.13M | 788.91M | 672.59M | 776.63M | 607.44M |
Account Payables | 24.8M | 23.53M | 41.68M | 17.29M | 15.14M | 12.13M |
Deferred Revenue | n/a | 2.82M | 7.1M | 11.98M | 16.27M | n/a |
Short-Term Debt | n/a | 68.68M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 44.71M | 49.46M | 94.32M | 47.99M | 39.59M | 62.26M |
Total Current Liabilities | 159.9M | 200.75M | 177.91M | 142.16M | 124.09M | 92.66M |
Long-Term Debt | 311.72M | 310.31M | 377.26M | 375.55M | 226.58M | 215.34M |
Other Long-Term Liabilities | 7.6M | 6.8M | 8.49M | 73.59M | 71.98M | 59.89M |
Total Long-Term Liabilities | 330.46M | 334.3M | 410.2M | 487.57M | 350.43M | 303.57M |
Total Liabilities | 490.36M | 535.05M | 588.1M | 629.73M | 474.52M | 396.23M |
Total Debt | 328.73M | 401.58M | 404.78M | 407.49M | 261.99M | 244.03M |
Book Value | 114.83M | 59.08M | 200.81M | 42.85M | 302.11M | 211.21M |
Book Value Per Share | 1.29 | 0.75 | 2.70 | 0.67 | 5.05 | 4.44 |
Common Stock | 9K | 9K | 7K | 6K | 6K | 5K |
Retained Earnings | -1.47B | -1.45B | -1.13B | -1.01B | -765.97M | -585.88M |
Comprehensive Income | -1.19M | -80K | -1.46M | -2.91M | -562K | -902K |
Shareholders Equity | 114.83M | 59.08M | 200.81M | 42.85M | 302.11M | 211.21M |
Total Investments | 229.76M | 312.17M | 508.68M | 388.56M | 387.13M | 276.82M |
Add to Watchlist
Select watchlists to add or remove TVTX